Page last updated: 2024-09-03

phosphoramide and Cystic Fibrosis of Pancreas

phosphoramide has been researched along with Cystic Fibrosis of Pancreas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berchel, M; Gill, D; Hyde, S; Jaffrès, PA; Laurent, V; Le Gall, T; Montier, T; Mottais, A; Sibiril, Y	1

Other Studies

1 other study(ies) available for phosphoramide and Cystic Fibrosis of Pancreas

Article	Year
Antibacterial effect and DNA delivery using a combination of an arsonium-containing lipophosphoramide with an N-heterocyclic carbene-silver complex - Potential benefits for cystic fibrosis lung gene therapy. International journal of pharmaceutics, 2018, Jan-30, Volume: 536, Issue:1 Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; DNA; Drug Carriers; Gene Transfer Techniques; Genetic Therapy; Gram-Positive Bacteria; Humans; Lung; Methane; Microbial Sensitivity Tests; Nanoparticles; Phosphoramides; Pseudomonas aeruginosa; Silver	2018

Article

Year

Antibacterial effect and DNA delivery using a combination of an arsonium-containing lipophosphoramide with an N-heterocyclic carbene-silver complex - Potential benefits for cystic fibrosis lung gene therapy.

International journal of pharmaceutics, 2018, Jan-30, Volume: 536, Issue:1

Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; DNA; Drug Carriers; Gene Transfer Techniques; Genetic Therapy; Gram-Positive Bacteria; Humans; Lung; Methane; Microbial Sensitivity Tests; Nanoparticles; Phosphoramides; Pseudomonas aeruginosa; Silver

2018